Jane Street’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Jane Street’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,997	Closed	-$358K	–	4977
2016 Q3	$358K	Buy	+8,997	New	+$100K	﹤0.01%	3122
2014 Q4	–	Sell	-2,473	Closed	-$25K	–	3368
2014 Q3	$25K	Sell	2,473 -1,604	-39%	-$31.7K	﹤0.01%	2461
2014 Q2	$249K	Buy	4,077 +1,319	+48%	+$80.2K	﹤0.01%	1998
2014 Q1	$311K	Buy	+2,758	New	+$194K	﹤0.01%	1960
2013 Q4	–	Sell	-1,622	Closed	-$98K	–	3201
2013 Q3	$98K	Buy	+1,622	New	+$85K	﹤0.01%	2549

Jane Street's TBRA Position: Q4 2016 in Review

Jane Street sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 8,997 shares — an estimated $358K sold.

Jane Street first reported a position in TBRA in Q3 2013 and held it in 5 quarters. The position peaked at $358K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Jane Street reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Jane Street sold 8,997 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $358K.
Jane Street first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
Jane Street's Tobira Therapeutics, Inc. Common Stock position peaked at $358K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Jane Street's 13F filing for Q4 2016, filed 15 Feb 2017.